DrugPatentWatch Database Preview

CLEOCIN Drug Profile

« Back to Dashboard

When do Cleocin patents expire, and when can generic versions of Cleocin launch?

Cleocin is a drug marketed by Pharmacia And Upjohn and is included in fourteen NDAs. There is one patent protecting this drug.

This drug has twenty-four patent family members in twenty-two countries.

The generic ingredient in CLEOCIN is clindamycin palmitate hydrochloride. There are fifty-five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the clindamycin palmitate hydrochloride profile page.

Summary for CLEOCIN

International Patents:	24
US Patents:	1
Applicants:	1
NDAs:	14
Suppliers / Packagers:	3
Bulk Api Vendors:	69
Clinical Trials:	8
Patent Applications:	1,179
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for CLEOCIN
DailyMed Link:	CLEOCIN at DailyMed

See drug prices for CLEOCIN

See drug sales revenues for CLEOCIN

Recent Clinical Trials for CLEOCIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Tianjin Medical University Cancer Institute and Hospital	N/A
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Phase 1
Michael Cohen-Wolkowiez	Phase 1

See all CLEOCIN clinical trials

Pharmacology for CLEOCIN

Drug Class	Lincosamide Antibacterial
Physiological Effect	Decreased Sebaceous Gland Activity

Synonyms for CLEOCIN

(2S-trans)-Methyl 7-Chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-D-erythro-|A-D-galactooctopyranoside Hydrochloride

(2S-trans)-Methyl 7-Chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-|A-D-galactooctopyranoside Hydrochloride

(2S,4R)-N-((1S,2S)-2-CHLORO-1-((2R,3R,4S,5R,6R)-3,4,5-TRIHYDROXY-6-(METHYLTHIO)TETRAHYDRO-2H-PYRAN-2-YL)PROPYL)-1-METHYL-4-PROPYLPYRROLIDINE-2-CARBOXAMIDE HYDROCHLORIDE

(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride

(2S,4R)-N-[(1S,2S)-2-chloro-1-[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride

17431-55-9

18323-44-9 (Parent)

21462-39-5

26884-28-6

32795-16-7

462C395

58207-19-5

7-Epi Clindamycin Hydrochloride

AB0071584

AB43001

AC-12179

AC1O4WFR

ACT02688

AKOS015843964

AKOS015960823

Antibiotic U 21251F Hydrochloride

Antirobe

Antirobe vet.

API0002053

AS-13649

AT-13884

AUODDLQVRAJAJM-XJQDNNTCSA-N

BCP11950

BenzaClin

BIC0117

C13684

CAS-21462-39-5

CC0172

CCG-212538

CHEMBL1200588

CHEMBL1452303

Cleocin HCl

Cleocin hydrochloride

Cleocin hydrochloride (TN)

Clindamycin (hydrochloride)

CLINDAMYCIN ALCOHOLATE

Clindamycin Hcl

Clindamycin HCl (Dalacin)

Clindamycin hydrochloride

Clindamycin hydrochloride (JP17/USP)

Clindamycin hydrochloride [USP:BAN:JAN]

clindamycin hydrochloride hydrochloride

Clindamycin hydrochloride monohydrate

Clindamycin hydrochloride, European Pharmacopoeia (EP) Reference Standard

Clindamycin hydrochloride, lincosamide antibiotic

Clindimycin hydrochloride

Clinsol

Clintabs

CS-2508

D02132

Dalacin (TN)

DSSTox_CID_25428

DSSTox_GSID_45428

DSSTox_RID_80872

DTXSID4045428

EC 244-398-6

HMS1568K16

HY-B0408A

J10047

MCULE-6809905039

Methyl 7-chloro-6,7,8-trideoxy-6-[(1-methyl-4-propylprolyl)amino]-1-thiooctopyranoside (HCl)

Methyl 7-Chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-D-erythro-|A-D-galactooctopyranoside Hydrochloride

Methyl-7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-?-D-galacto-octopyranoside hydrochloride

MFCD03253991

MFCD07793327

MFCD07793327 (97+%)

MLS000069765

MolPort-003-983-294

NCGC00016752-01

NSC-305832

NSC-756696

NSC305832

NSC756696

Pharmakon1600-01500193

Prestwick_69

SCHEMBL3153

SMR000058902

SR-01000722035

SR-01000722035-3

ST2406750

SY006928

T20OQ1YN1W

Tox21_110591

U 21251F

U-25179E

UNII-T20OQ1YN1W

Z-4007

ZX-AFC000484

US Patents and Regulatory Information for CLEOCIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmacia And Upjohn	CLEOCIN	clindamycin hydrochloride	CAPSULE;ORAL	061809-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Pharmacia And Upjohn	CLEOCIN T	clindamycin phosphate	GEL;TOPICAL	050615-001	Jan 7, 1987	AB	RX	Yes	Yes
Pharmacia And Upjohn	CLEOCIN	clindamycin phosphate	SUPPOSITORY;VAGINAL	050767-001	Aug 13, 1999		RX	Yes	Yes			Y
Pharmacia And Upjohn	CLEOCIN	clindamycin phosphate	CREAM;VAGINAL	050680-002	Mar 2, 1998	AB	RX	Yes	Yes
Pharmacia And Upjohn	CLEOCIN PHOSPHATE	clindamycin phosphate	INJECTABLE;INJECTION	061839-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Pharmacia And Upjohn	CLEOCIN T	clindamycin phosphate	SOLUTION;TOPICAL	062363-001	Feb 8, 1982		DISCN	No	No
Pharmacia And Upjohn	CLEOCIN	clindamycin phosphate	SWAB;TOPICAL	050537-002	Feb 22, 1994	AT	RX	Yes	No

International Patents for CLEOCIN

Country	Patent Number	Estimated Expiration
Honduras	2000000166
China	1360495
Denmark	1200065
Argentina	025045
Australia	768907
Mexico	PA02001320
Slovenia	1200065

Supplementary Protection Certificates for CLEOCIN

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1304992	122013000081	Germany		PRODUCT NAME: CLINDAMYCIN (ALS CLINDAMYCIN-PHOSPHAT) UND TRETINOIN; NAT. REGISTRATION NO/DATE: 85210.00.00 20130611; FIRST REGISTRATION: IRLAND PA1332/043/001 20130322
1304992	C300617	Netherlands		PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
1304992	PA2013025,C1304992	Lithuania		PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
1304992	SPC/GB13/061	United Kingdom		PRODUCT NAME: CLINDAMYCIN PHOSPHATE IN COMBINATION WITH TRETINOIN.; REGISTERED: IE PA1332/043/001 20130322; UK PL15142/0249 20130624
1304992	2013/044	Ireland		PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
1304992	CR 2013 00053	Denmark		PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
1304992	2013C/060	Belgium		PRODUCT NAME: CLINDAMYCINE (ALS CLINDAMYCINE FOSFAAT) EN TRETINOINE; AUTHORISATION NUMBER AND DATE: BE437507 20130506